Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
14
NMPA:14
Drug Approvals
Teicoplanin for Injection
- Product Name
- 注射用替考拉宁
- Approval Number
- 国药准字H20253606
- Approval Date
- Mar 11, 2025
NMPA
Compound Glycyrrhizin Tablets
- Product Name
- 复方甘草酸苷片
- Approval Number
- 国药准字H20253068
- Approval Date
- Jan 8, 2025
NMPA
Neostigmine Methylsulfate Injection
- Product Name
- 甲硫酸新斯的明注射液
- Approval Number
- 国药准字H20249616
- Approval Date
- Dec 1, 2024
NMPA
Neostigmine Methylsulfate Injection
- Product Name
- 甲硫酸新斯的明注射液
- Approval Number
- 国药准字H20249617
- Approval Date
- Dec 1, 2024
NMPA
Metoclopramide Hydrochloride Injection
- Product Name
- 盐酸甲氧氯普胺注射液
- Approval Number
- 国药准字H20249639
- Approval Date
- Dec 1, 2024
NMPA
Lornoxicam for Injection
- Product Name
- 注射用氯诺昔康
- Approval Number
- 国药准字H20249406
- Approval Date
- Nov 15, 2024
NMPA
Diprophylline Injection
- Product Name
- 二羟丙茶碱注射液
- Approval Number
- 国药准字H20244527
- Approval Date
- Jul 30, 2024
NMPA
Ampicillin Sodium for Injection
- Product Name
- 注射用氨苄西林钠
- Approval Number
- 国药准字H20247078
- Approval Date
- Apr 19, 2024
NMPA
Ampicillin Sodium for Injection
- Product Name
- 注射用氨苄西林钠
- Approval Number
- 国药准字H20247082
- Approval Date
- Apr 19, 2024
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found